Ampio Pharmaceuticals, Inc.

AMPE

US03209T3077

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 03:48:33 2024-04-16 pm EDT			5-day change	1st Jan Change
0.3 ^USD	0.00%		-65.91%	-85.37%

Apr. 15	Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index	CI
Mar. 27	Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index	Apr. 14	CI
Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Top Midday Decliners	Mar. 26	MT
US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings	Mar. 26	MT
Top Premarket Decliners	Mar. 26	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Durable Goods, Consumer Confidence Data	Mar. 26	MT
Ampio Pharmaceuticals Takes Voluntary Decision to Delist From NYSE American; Shares Plunge Premarket	Mar. 26	MT
North American Morning Briefing : Stocks Struggle After New Records	Mar. 22	DJ
Ampio Pharmaceuticals, Inc. Provides Update on Results from Pre-IND Enabling Studies	Feb. 14	CI
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech	Dec. 01	MT
Top Premarket Decliners	Dec. 01	MT
Top Premarket Gainers	Nov. 30	MT
Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Ampio Pharmaceuticals, Inc. Contemplates Bankruptcy .	Nov. 14	CI
Ampio Picks Ascendia Pharmaceuticals to Support OA-201's Clinical Development	23-10-05	MT
Ampio Pharmaceuticals to Effect 20-to-1 Reverse Stock Split	23-08-31	MT
Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Ampio Pharmaceuticals, Inc. Announces Change of Principal Executive Office	23-07-05	CI
Wall Street Set to Open Mixed; Jobless Claims Higher Than Expected, PPI Lower Than Expected	23-05-11	MT
US Futures Trends Mostly Lower Ahead of Jobs Report, Producer Price Index Data	23-05-11	MT
Top Premarket Gainers	23-05-11	MT
Ampio Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI
Ampio Pharmaceuticals Shares Soar After Company Letter on Drug Development, Cost-Cutting Efforts	23-04-18	MT
Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Ampio Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	23-03-26	CI

Chart Ampio Pharmaceuticals, Inc.

Duration

Period

More charts

Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Sector

Biotechnology & Medical Research

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
AMPIO PHARMACEUTICALS, INC.	-85.37%	704K
VERTEX PHARMACEUTICALS INCORPORATED	-3.13%	103B
REGENERON PHARMACEUTICALS, INC.	+1.80%	96.56B
ARGENX SE	+1.72%	22.61B
BIONTECH SE	-18.19%	21.18B
GENMAB A/S	-4.50%	19.07B
WUXI APPTEC CO., LTD.	-41.75%	16.53B
BEIGENE, LTD.	-25.68%	14.46B
NEUROCRINE BIOSCIENCES, INC.	+0.93%	13.25B
SAREPTA THERAPEUTICS, INC.	+21.63%	11.1B